Showing 192 news articles about Drug interactions & pharmacokinetics

Filters Content type: News Topic: Drug interactions & pharmacokinetics

Taking two or more different drugs together may result in an alteration in the effectiveness or in the side-effects of one or more of the drugs. Pharmacokinetics (PK) is the study of how a drug is absorbed into the body and distributed in different parts of the body. Pharmacodynamics (PD) is the study of the impact of different concentrations of a drug on the body.

Ageing & HIV

The US opioid crisis has reached older people with HIV

News
28 March 2024
PrEP policies & guidelines

Should event-driven PrEP be an option for women?

News
19 March 2024
The search for a cure

Varying dolutegravir distribution across the body may affect the drug’s ability to suppress the HIV reservoir

News
5 March 2024
Ageing & HIV

Too many older people with HIV taking medicines they may not need

News
2 February 2024
Injectable & long-acting HIV treatment

Cabotegravir levels lower than trials in real-world study, but no increase in viral rebound

News
1 February 2024
PrEP science

Oral PrEP can work just as well for women as men, modelling studies conclude

News
29 December 2023
Changing treatment

Increasing and changing pattern of treatment switches among people with HIV

News
23 October 2023
Pregnancy and vertical transmission

Bictegravir safe and effective in pregnancy

News
25 July 2023
TB treatment

Once-daily dolutegravir sufficient when taking TB treatment

News
16 June 2023
Drug interactions & pharmacokinetics

Can testing for drug-gene interactions improve treatment success in people with HIV?

News
15 June 2023
Injectable & long-acting PrEP

Good news for women and PrEP: quarterly dosing may work

News
23 February 2023
Ageing & HIV

Anticholinergic medications associated with falls and frailty in people ageing with HIV

News
15 February 2022
PrEP science

One dose of TAF every three days gets more drug into cells than a daily dose of TDF

News
17 September 2021
Transgender people

Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa

News
22 July 2021
Drug interactions & pharmacokinetics

Elderly women more likely than men to have inappropriately prescribed medicines

News
25 March 2021
Drug interactions & pharmacokinetics

PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women

News
16 March 2021
Contraception

Doubling the dose of emergency contraception is a safe and effective way of overcoming efavirenz interaction

News
15 March 2021
PrEP science

HPTN 083: Injectable PrEP can make breakthrough infections hard to detect

News
10 March 2021
Injectable & long-acting PrEP

Reformulated islatravir implant should provide PrEP for over a year

News
9 March 2021
Injectable & long-acting PrEP

Once-a-month PrEP pill easily passes its first big test

News
27 January 2021
Drug interactions & pharmacokinetics

Study finds diabetes is associated with a 25% reduction in concentration of tenofovir in blood spot samples, but what are the causes and consequences?

News
20 October 2020
Injectable & long-acting HIV treatment

New once-a-week drug could be part of weekly oral treatment

News
13 October 2020
Weight gain & lipodystrophy

Genetics may contribute to weight gain after switching from efavirenz to an integrase inhibitor

News
2 October 2020
HIV treatment for children & young people

Adult doses of dolutegravir can be used by children weighing 20 kg or more

News
15 September 2020